RGD Reference Report - Novel arterial pathology in mice and humans hemizygous for elastin. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Novel arterial pathology in mice and humans hemizygous for elastin.

Authors: Li, DY  Faury, G  Taylor, DG  Davis, EC  Boyle, WA  Mecham, RP  Stenzel, P  Boak, B  Keating, MT 
Citation: Li DY, etal., J Clin Invest 1998 Nov 15;102(10):1783-7.
RGD ID: 734930
Pubmed: PMID:9819363   (View Abstract at PubMed)
PMCID: PMC509127   (View Article at PubMed Central)
DOI: DOI:10.1172/JCI4487   (Journal Full-text)

Obstructive vascular disease is an important health problem in the industrialized world. Through a series of molecular genetic studies, we demonstrated that loss-of-function mutations in one elastin allele cause an inherited obstructive arterial disease, supravalvular aortic stenosis (SVAS). To define the mechanism of elastin's effect, we generated mice hemizygous for the elastin gene (ELN +/-). Although ELN mRNA and protein were reduced by 50% in ELN +/- mice, arterial compliance at physiologic pressures was nearly normal. This discrepancy was explained by a paradoxical increase of 35% in the number of elastic lamellae and smooth muscle in ELN +/- arteries. Examination of humans with ELN hemizygosity revealed a 2. 5-fold increase in elastic lamellae and smooth muscle. Thus, ELN hemizygosity in mice and humans induces a compensatory increase in the number of rings of elastic lamellae and smooth muscle during arterial development. Humans are exquisitely sensitive to reduced ELN expression, developing profound arterial thickening and markedly increased risk of obstructive vascular disease.

Objects referenced in this article
Gene Eln elastin Mus musculus

Additional Information